JPS61109716A - Agent for inhibiting growth of dental caries bacteria - Google Patents
Agent for inhibiting growth of dental caries bacteriaInfo
- Publication number
- JPS61109716A JPS61109716A JP22897384A JP22897384A JPS61109716A JP S61109716 A JPS61109716 A JP S61109716A JP 22897384 A JP22897384 A JP 22897384A JP 22897384 A JP22897384 A JP 22897384A JP S61109716 A JPS61109716 A JP S61109716A
- Authority
- JP
- Japan
- Prior art keywords
- maltol
- bacteria
- agent
- dental caries
- inhibiting growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pyrane Compounds (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明はう負(虫歯)の形成に大きく関与しているスト
レプトコッカス・ミュータンス(Strepto−co
ccus mutans)に代表される口腔内細菌に対
して優れた抗菌活性を余す、う負菌生育阻害剤に関する
。Detailed Description of the Invention (Industrial Application Field) The present invention is directed to the treatment of Streptococcus mutans, which is greatly involved in the formation of dental cavities.
The present invention relates to a caries growth inhibitor that has excellent antibacterial activity against oral bacteria such as C. ccus mutans.
(従来の技術)
従来、口腔内細菌の生育を阻害する薬剤としてはクロル
ヘキシジン、抗生物質等の使用が知られている外、多く
の合成品、天然品が報告されている。(Prior Art) Chlorhexidine, antibiotics, and the like have been known to be used as drugs that inhibit the growth of oral bacteria, and many synthetic and natural products have been reported.
(発明が解決しようとする問題点)
しかしながら、これら公知の口腔内細菌の生育阻害剤は
投与方法、投与量に、よっては人体に対する安全性に問
題があったり、安定性が確認されているものは抗菌性が
低かったり、また投与した際。(Problems to be Solved by the Invention) However, these known oral bacteria growth inhibitors may have problems with their safety to the human body depending on the administration method and dosage, or their stability has not been confirmed. has low antibacterial properties or when administered.
不快な臭がするなどの欠点があった。There were drawbacks such as an unpleasant odor.
本発明の目的は人体に対する安全性が確認されており、
且つ抗菌性が高く、しかも快い芳香を有するう負菌生育
阻害剤を提供することにある。The purpose of the present invention is to ensure safety for the human body,
It is an object of the present invention to provide a caries growth inhibitor that has high antibacterial properties and a pleasant aroma.
(問題点を解決するための手段)
本発明によれば、マルトール及び/またはエチルマルト
ールを有効成分として含有することを特徴とするう負菌
生育阻害剤が提供される。(Means for Solving the Problems) According to the present invention, a fungal growth inhibitor characterized by containing maltol and/or ethyl maltol as an active ingredient is provided.
以下本発明につき更に詳細に説明する。The present invention will be explained in more detail below.
一般的にう負(虫歯)形成の原因としては歯質(τae
th)と基質(Substrate)とミュータンス菌
(St、層utans)とを挙げる4とができ、この3
つの要因が同時に存在するとき、う負(虫歯)が発生す
るとされている。う負(虫歯)形成のメカニズムは1例
えば糖類の中で砂糖を基質(Substrata)とし
た場合、この砂糖がミュータンス菌(St、mutan
s)の産出するグルコキシトランスフェラーゼ(酵素)
によフて水に不溶性で粘着性のデキストラン(グルカン
、)に変化し、歯質(Teeth)の表面に歯垢を形成
する。この歯垢の中では嫌気状態となり乳酸−菌等によ
り醗酵が進み乳酸が生成してPHが低下し、この乳酸が
歯のエナメル質を脱灰しう負(虫歯)を形成するとされ
ている。Generally, the cause of cavities (caries) formation is the tooth structure (τae).
th), Substrate, and Streptococcus mutans (St), and these 3
Cavities (tooth decay) are said to occur when these two factors exist at the same time. The mechanism of cavities (dental caries) formation is 1. For example, when sugar is used as a substrate, this sugar becomes Streptococcus mutans (St, mutan).
Glucoxytransferase (enzyme) produced by s)
When absorbed, it changes into water-insoluble and sticky dextran (glucan), forming dental plaque on the surface of teeth. This dental plaque becomes anaerobic and fermentation proceeds by lactic acid bacteria and the like, producing lactic acid and lowering the pH. It is said that this lactic acid demineralizes tooth enamel and forms cavities (cavities).
従って、ストレプトコッカス・ミュータンス(St、s
+utans)に代表される口腔内細菌の増殖を抑え歯
垢の形成を阻止することはう負(虫歯)の形成を予防す
る有効な方法である0本発明者等は既に人体に安全性が
確認され且う負(虫歯)形成に大きく関与しているスト
レプトコッカス・ミュータンス菌(St、mutans
)の生育を阻害する条件に適合する物質を鋭意探索研究
した結果、マルトール及び/またはエチルマルトールが
非常に有効であることを見出し1本発明を完成するに至
った。Therefore, Streptococcus mutans (St, s
Suppressing the growth of oral bacteria, such as utans), and inhibiting the formation of dental plaque is an effective method for preventing the formation of cavities (cavities). Streptococcus mutans (St, mutans), which is greatly involved in the formation of negative (dental caries)
) As a result of intensive search and research for substances that meet the conditions for inhibiting the growth of the following, it was discovered that maltol and/or ethyl maltol are very effective, leading to the completion of the present invention.
本発明にて用いるマルトール及びエチルマルトールはす
でに公知物質であり、下記に差の化学構造式及び化学名
を示す。Maltol and ethylmaltol used in the present invention are already known substances, and the different chemical structural formulas and chemical names are shown below.
本発明にて用いるマルトールは市販品1例えばピロマト
ール(大域化学■、商品名)及びペルトール(ファイザ
ー■、商品名)またエチルマルトールは市販品1例えば
ビロマトールE(大塚化学■、商品名)及びペルトール
プラス(ファイザーー、市販品)を使用することができ
る。The maltol used in the present invention is a commercially available product such as pyromatol (Gaikyo Kagaku ■, trade name) and peltol (Pfizer ■, trade name), and the ethyl maltol is a commercially available product such as viromatol E (Otsuka Chemical ■, trade name) and peltol. Plus (Pfizer, commercially available product) can be used.
本発明にて用いるマルトール及びエチルマルトールはG
RASリスト(Na2656. Na3487)及びF
DAIJXト(li121−1164.1121−11
64) ニ各々記載の既に安全性の確認された香料物質
であり。Maltol and ethyl maltol used in the present invention are G
RAS list (Na2656.Na3487) and F
DAIJX (li121-1164.1121-11
64) Each of the above fragrance substances has already been confirmed to be safe.
香味剤または香味改良増強剤(Flavor enha
ncer)として、例えばチョコレート製品、パン類、
砂糖菓子、アルコール飲料、肉製品、酪農製品、アイス
クリーム、缶詰食品、タバコ、歯磨1口紅、保健製品、
動物飼料等に広く利用されている。〔香料化学総覧(■
)、奥田治著、904頁、広角書店発行〕。Flavoring agents or flavor enhancers
(cer) such as chocolate products, breads,
Sugar confectionery, alcoholic beverages, meat products, dairy products, ice cream, canned foods, tobacco, toothpaste, lipstick, health products,
Widely used as animal feed. [Overview of fragrance chemistry (■
), Osamu Okuda, 904 pages, published by Hirokaku Shoten].
この様な口腔内で快い芳香を漂わせる香料物質がう負菌
生育阻害剤として優れた効果を示すことは驚くべき事で
ある。It is surprising that a flavoring substance that gives off a pleasant aroma in the oral cavity exhibits excellent effects as a growth inhibitor of caries bacteria.
本発明のマルトールとエチルマルトールとは併用しても
よく、また一方のみを単独で用いてもよ塾1゜
本発明のう負菌生育阻害剤の投与形態としては口腔中で
比較的滞留時間の長い錠果、チューインガム、キャンデ
ー、トローチ等に配合させることによりその効果が期待
できる外、本発明のう負菌生育阻害剤は界面活性剤によ
る抗菌活性も殆ど無いので歯磨、マウスウオシュ等の口
腔清浄剤にも配合しても使用できる。その配合量は対象
製品の形態1種類等によって必ずしも一様ではないがロ
腔用組成物中o、oos%〜10重量%、好ましくは0
.01〜5重量%配合するのが一般的である。The maltol and ethyl maltol of the present invention may be used in combination, or one may be used alone. In addition to being expected to be effective when incorporated into long tablets, chewing gum, candies, troches, etc., the caries growth inhibitor of the present invention has almost no antibacterial activity due to surfactants, so it can be used in oral cleaning agents such as toothpastes and mouthwashes. It can also be used in combination with The amount incorporated is not necessarily uniform depending on the form of the target product, etc., but it is preferably 0% to 10% by weight in the composition for oral cavities.
.. Generally, it is blended in an amount of 0.01 to 5% by weight.
本発明のう負菌生育阻害剤を配合した処方例を下記に示
す。Examples of formulations containing the caries growth inhibitor of the present invention are shown below.
処方例−1
常法に従い、以下に示す組成のチューインガムを製造し
た。Formulation Example-1 Chewing gum having the composition shown below was manufactured according to a conventional method.
一處一一分一一 重量%ガムベース
20粉糖 35
マルトース 10フルクトース
10水アメ
15香料 1
マルトール 0.4部
100%
処方例−2
常法に従い、以下に示す組成のマウスウオシュを製造し
た。1 1 1 1 1 Weight % Gum base
20 powdered sugar 35 maltose 10 fructose
10 water candy
15 Fragrance 1 Maltol 0.4 part 100% Prescription Example-2 A mouthwash having the composition shown below was manufactured according to a conventional method.
一虚−−分一一 重量%エタノール
20サッカリン
0.5グリセリン 50
シヨ糖ラウリレート 2クロルヘキシ
ジン 0.5香料 1
エチルマルトール 0.5水
100%
処方例−3
常法に従い、以下に示す組成のトローチを製造した。1 imaginary - 11 weight% ethanol
20 saccharin
0.5 Glycerin 50 Sucrose laurylate 2 Chlorhexidine 0.5 Flavor 1 Ethyl maltol 0.5 Water 100% Formulation Example 3 A troche having the composition shown below was produced according to a conventional method.
−1−−」L−一 −−JU1虹−−アラ
ビアガム 8マルトース
30フルクトース
20グルコース 20香料
0.2
マルトール 0.2100%
(実施例)
次に本発明のマルトール及びエチルマルトールの抗菌活
性効果を実施例により本発明を更に詳細に説明する。-1--" L-1 --JU1 Rainbow-- Gum Arabic 8 Maltose
30 fructose
20 Glucose 20 Flavor
0.2 Maltol 0.2100% (Example) Next, the antibacterial activity effect of maltol and ethyl maltol of the present invention will be explained in more detail with reference to Examples.
実施例−1) ペプトン1%、酵母エキス0.5%、ショ糖2%。Example-1) 1% peptone, 0.5% yeast extract, 2% sucrose.
PH7,0の寒天培地を調製し、滅菌冷却後、これに2
4時間培養したストレプトコッカス・ミュータンス(S
treptococcus mutang) RI M
D−3125001株の培養液0.5%を添加し、直
ちに直径80■の滅菌シャーレに12−づつ分注した0
次に直径8■のペパーディスクに試料化合物を含浸させ
、上記のシャーレの寒天培地中央にのせ、37℃にて7
2時間倒置培養した。Prepare an agar medium with a pH of 7.0, and after sterilizing and cooling it, add 2
Streptococcus mutans (S
treptococcus mutang) RI M
0.5% of the culture solution of strain D-3125001 was added and immediately dispensed into 12-diameter sterile Petri dishes.
Next, a pepper disk with a diameter of 8 cm was impregnated with the sample compound, placed on the center of the agar medium of the above Petri dish, and heated at 37℃ for 7 days.
The cells were incubated inverted for 2 hours.
抗菌活性の試験(予備テスト)の判定は次の様にして行
った。透明な寒天培地は菌が増殖すると白濁してくるが
試料の抗菌活性が有ればペパーディスク周辺は透明が保
持されるので、このクリアゾーン(以下阻止円直径とい
う)を測定して、その阻止円直径401以上を増殖阻止
効果が有効であると評価した。The antibacterial activity test (preliminary test) was evaluated as follows. A transparent agar medium becomes cloudy when bacteria multiply, but if the sample has antibacterial activity, the area around the pepper disk will remain transparent, so this clear zone (hereinafter referred to as the inhibition circle diameter) will be measured to determine the inhibition. A circle diameter of 401 mm or more was evaluated as having an effective proliferation inhibiting effect.
効果
表−1の結果からマルトールは優れた菌の増殖効果を示
したが、殊にエチルマルトールは極めて著しい阻止効果
を示した。From the results in Effect Table 1, maltol showed an excellent bacterial growth effect, and ethyl maltol in particular showed a very remarkable inhibiting effect.
実施例−2) 。Example-2).
ショ糖2%添加のハートインフュージョン寒天培地(p
H7,0)を使用した以外は実施例1と同じミュータン
ス菌を用い、同じ方法で実施した結果1次の表−2で示
される結果が得られた。Heart infusion agar medium supplemented with 2% sucrose (p
Streptococcus mutans was used as in Example 1 except that H7.0) was used, and the same method was used. As a result, the results shown in Table 2 below were obtained.
(以下余白)
表−2ストレプトコッカスミュータンス表−2の結果か
らマルトールは優れた増殖阻止効果を示したが、殊にエ
チルマルトールは極めて著しい阻止効果を示した。(Margin below) Table 2 Streptococcus mutans From the results shown in Table 2, maltol showed an excellent growth inhibiting effect, and ethyl maltol in particular showed a very remarkable inhibiting effect.
実施例−3)
ストレプトコッカス・ミュータンス(Strepto−
coccus mutang) RI M D −31
25002(E49)株を使用する以外は実施例−1と
同じ培地を用い、同じ方法で実施した結果1次の表−3
で示される結果が得られた。Example-3) Streptococcus mutans (Streptococcus mutans)
coccus mutang) RI M D-31
The results were carried out using the same medium and the same method as in Example 1, except for using the 25002 (E49) strain.
The results shown are obtained.
表−3ストレプトコッカスミュータンス効果
表−3の結果からマルトール及びエチルマルトールども
極めて著しい菌増殖の阻止効果を示した。Table 3 Effect on Streptococcus mutans From the results shown in Table 3, maltol and ethyl maltol showed extremely remarkable effects on inhibiting bacterial growth.
実施例−4)
ショ糖2%添加のハートインフュージョンブイヨンの液
体培地(pH7,0)にマルトール0.02%(1/5
oon濃度)添加し、これに前培養しておいたストレプ
トコッカス・ミュータンス(Strepto−cocc
us mutans)3125001株の培養液を0.
5%添加し、窒素デシケタ−中で37℃にて24時間培
養し、菌の生育状態をチェックした結果、培地のpHの
低下もなく、またグルカンの形成も見られなかった事に
より、完全に菌の生育を阻止することができた。また本
試料の実用化を目的にソジウムラウリルサルフェート0
.5%の共存下における抗菌活性を測定した所、無添加
と比較し何ら活性の低下は認められなかった。Example-4) 0.02% maltol (1/5
Streptococcus mutans (Streptococcus mutans), which had been pre-cultured
0.0.0.0.
5% and cultured at 37°C in a nitrogen desiccator for 24 hours, and the growth status of the bacteria was checked. As a result, there was no decrease in the pH of the culture medium, and no glucan formation was observed. We were able to prevent the growth of bacteria. In addition, for the purpose of practical use of this sample, sodium lauryl sulfate 0
.. When antibacterial activity was measured in the presence of 5%, no decrease in activity was observed compared to when no additive was added.
実施例−5)
試験試料をエチルマルトール0.02%(11500G
濃度)を使用する以外実施例−4と同じ培地(pH7,
0) 、菌及び方法で実施した結果、培地のpHの低下
もなく、またグルカンの形成も見られなかった事により
、完全に菌の生育を阻止することができた。Example-5) The test sample was 0.02% ethyl maltol (11500G
The same medium (pH 7,
0), the bacteria and method showed that there was no decrease in the pH of the culture medium and no glucan formation was observed, making it possible to completely inhibit the growth of the bacteria.
Claims (1)
して含有することを特徴とするう蝕菌生育阻害剤。A caries growth inhibitor characterized by containing maltol and/or ethyl maltol as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22897384A JPS61109716A (en) | 1984-11-01 | 1984-11-01 | Agent for inhibiting growth of dental caries bacteria |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22897384A JPS61109716A (en) | 1984-11-01 | 1984-11-01 | Agent for inhibiting growth of dental caries bacteria |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS61109716A true JPS61109716A (en) | 1986-05-28 |
JPH0434968B2 JPH0434968B2 (en) | 1992-06-09 |
Family
ID=16884770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP22897384A Granted JPS61109716A (en) | 1984-11-01 | 1984-11-01 | Agent for inhibiting growth of dental caries bacteria |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS61109716A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6287541B1 (en) * | 1998-09-23 | 2001-09-11 | Chesebrough-Pond's Usa Co., Divison Of Conopco, Inc. | Oral care compositions |
JP2019506404A (en) * | 2016-01-19 | 2019-03-07 | アクロマズ、プライベート、リミテッドAchromaz Pte. Ltd. | Cosmetic composition and its use for conditioning skin quality |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5037260A (en) * | 1973-06-23 | 1975-04-07 | ||
JPS5141446A (en) * | 1974-08-09 | 1976-04-07 | Procter & Gamble | Shiko mushiba oyobi shisekiochensaserutameno osenkeikonogenshoshitakokoyososeibutsu |
JPS51139639A (en) * | 1975-04-01 | 1976-12-02 | Procter & Gamble | Tartar preventive composition |
JPS568679A (en) * | 1979-04-11 | 1981-01-29 | Fichera A T | Composition for controlling tobacco smoking and production thereof |
-
1984
- 1984-11-01 JP JP22897384A patent/JPS61109716A/en active Granted
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5037260A (en) * | 1973-06-23 | 1975-04-07 | ||
JPS5141446A (en) * | 1974-08-09 | 1976-04-07 | Procter & Gamble | Shiko mushiba oyobi shisekiochensaserutameno osenkeikonogenshoshitakokoyososeibutsu |
JPS51139639A (en) * | 1975-04-01 | 1976-12-02 | Procter & Gamble | Tartar preventive composition |
JPS568679A (en) * | 1979-04-11 | 1981-01-29 | Fichera A T | Composition for controlling tobacco smoking and production thereof |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6287541B1 (en) * | 1998-09-23 | 2001-09-11 | Chesebrough-Pond's Usa Co., Divison Of Conopco, Inc. | Oral care compositions |
JP2019506404A (en) * | 2016-01-19 | 2019-03-07 | アクロマズ、プライベート、リミテッドAchromaz Pte. Ltd. | Cosmetic composition and its use for conditioning skin quality |
US11123279B2 (en) | 2016-01-19 | 2021-09-21 | Achromaz Pte. Ltd. | Cosmetic composition and the use thereof for regulating skin quality |
Also Published As
Publication number | Publication date |
---|---|
JPH0434968B2 (en) | 1992-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0662408B2 (en) | Anti-caries and anti-periodontal composition | |
JP3614479B2 (en) | Periodontal disease-causing bacteria or caries-causing bacteria inhibitor, oral composition and food containing them | |
JPS61171423A (en) | Drug for alleviating dental caries and periodontosis | |
JPS63211219A (en) | Preventive for dental caries | |
US3427380A (en) | Oral compositions for retarding dental plaque formation comprising para-aminobenzoic acid | |
JP3481269B2 (en) | Antibacterial composition and antibacterial method | |
JP3009531B2 (en) | Periodontal disease prevention agent | |
JPS61109716A (en) | Agent for inhibiting growth of dental caries bacteria | |
KR100621191B1 (en) | Polylysine including composition for dental cleaning cloth | |
KR20030089047A (en) | Composition for enhancing oral health | |
KR102269164B1 (en) | Composition for improvement of dental caries and periodontal disease using an extract of seeds of Phaseolus radiatus, etc. | |
JPS5835484B2 (en) | Oral composition | |
CN113694006A (en) | Tooth-care toothpaste capable of effectively inhibiting dental plaque | |
JPS61268613A (en) | Composition for oral cavity containing evening primrose seed oil | |
JP2000327581A (en) | Composition for sterilizing oral cavity | |
JPH07133222A (en) | Glucosyl transferase inhibitor | |
JPH05255101A (en) | Inhibitor for adhesion of microorganism to animal cell | |
WO2011056327A1 (en) | Omega polyunsaturated fatty acids for the treatment of oral diseases | |
JPH0466524A (en) | Composition for use in oral cavity | |
JP2001321123A (en) | Anticariogenic food material and its composition | |
KR20140055885A (en) | The gargle composites for the increment of the oral care | |
JPS6258324B2 (en) | ||
JP7362417B2 (en) | Growth inhibitors, oral compositions, and promoters of oral pathogenic bacteria | |
JPS5812251B2 (en) | Oral composition | |
JPS61260017A (en) | Composition for oral cavity application having caries-preventive effect |